Skip to main content
Top
Published in: Surgery Today 3/2016

01-03-2016 | Original Article

Which prosthesis is more resistant to vascular graft infection: polytetrafluoroethylene or Omniflow II biosynthetic grafts?

Authors: Orhan Bozoglan, Bulent Mese, Erdinc Eroglu, Serdal Elveren, Mustafa Gul, Ahmet Celik, Halil Ibrahim Yildirimdemir, Harun Ciralik, Alptekin Yasim

Published in: Surgery Today | Issue 3/2016

Login to get access

Abstract

Purpose

The aim of this study was to determine whether polytetrafluoroethylene grafts or Omniflow II biosynthetic grafts are more resistant to infection caused by Staphylococcus aureus.

Methods

Sixty rats were divided into six groups. In Groups 1A, 1B and 1C, a polytetrafluoroethylene graft was implanted in each rat, and, in Groups 2A, 2B and 2C, a biosynthetic graft was implanted in each rat. Staphylococcus aureus was inoculated into Groups 1B, 1C, 2B and 2C, and the rats in Groups 1C and 2C were treated with teicoplanin. One week later, the rats were euthanized, the grafts were removed and a microbiological count was performed. A histopathological examination was subsequently carried out, and the C-reactive protein, prealbumin and leukocyte levels were investigated.

Results

There were no significant differences in the C-reactive protein, prealbumin and leukocyte levels. The differences in the results of the microbiological evaluations between the groups were significant. The quantitative culture results showed no bacterial growth in Groups 1A, 1C and 2A. The number of bacteria in Group 1B was statistically lower than that in Group 2B. When the groups receiving treatment were compared, Group 2C had bacterial growth, whereas Group 1C did not. The histopathological examinations showed similar results.

Conclusions

Omniflow II grafts are more susceptible to infection than polytetrafluoroethylene grafts.
Literature
1.
go back to reference Antonios VS, Noel AA, Steckelberg JM, Wilson WR, Mandrekar JN, Harmsen WS, et al. Prosthetic vascular graft infection: a risk factor analysis using a case-control study. J Infect. 2006;53:49–55.CrossRefPubMed Antonios VS, Noel AA, Steckelberg JM, Wilson WR, Mandrekar JN, Harmsen WS, et al. Prosthetic vascular graft infection: a risk factor analysis using a case-control study. J Infect. 2006;53:49–55.CrossRefPubMed
2.
go back to reference Seeger JM, Pretus HA, Welborn MB, Ozaki CK, Flynn TC, Huber TS. Long-term outcome after treatment of aortic graft infection with staged extra-anatomic bypass grafting and aortic graft removal. J Vasc Surg. 2000;32:451–9.CrossRefPubMed Seeger JM, Pretus HA, Welborn MB, Ozaki CK, Flynn TC, Huber TS. Long-term outcome after treatment of aortic graft infection with staged extra-anatomic bypass grafting and aortic graft removal. J Vasc Surg. 2000;32:451–9.CrossRefPubMed
3.
go back to reference Alp E, Elmali F, Ersoy S, Kucuk C, Doganay M. Incidence and risk factors of surgical site infection in general surgery in a developing country. Surg Today. 2014;44:685–9.CrossRefPubMed Alp E, Elmali F, Ersoy S, Kucuk C, Doganay M. Incidence and risk factors of surgical site infection in general surgery in a developing country. Surg Today. 2014;44:685–9.CrossRefPubMed
4.
go back to reference Stewart AH, Eyers PS, Earnshaw JJ. Prevention of infection in peripheral arterial reconstruction: a systematic review and meta-analysis. J Vasc Surg. 2007;46:148–55.CrossRefPubMed Stewart AH, Eyers PS, Earnshaw JJ. Prevention of infection in peripheral arterial reconstruction: a systematic review and meta-analysis. J Vasc Surg. 2007;46:148–55.CrossRefPubMed
5.
go back to reference Giacometti A, Ghiselli R, Cirioni O, Mocchegiani F, Orlando F, Del Prete MS, et al. Prophylactic efficacy of linezolid alone or combined with levofloxacin and vancomycin in a rat subcutaneous pouch model of graft infection caused by Staphylococcus epidermidis with intermediate resistance to glycopeptides. J Antimicrob Chemother. 2003;52:724–6.CrossRefPubMed Giacometti A, Ghiselli R, Cirioni O, Mocchegiani F, Orlando F, Del Prete MS, et al. Prophylactic efficacy of linezolid alone or combined with levofloxacin and vancomycin in a rat subcutaneous pouch model of graft infection caused by Staphylococcus epidermidis with intermediate resistance to glycopeptides. J Antimicrob Chemother. 2003;52:724–6.CrossRefPubMed
6.
go back to reference Campoli-Richards DM, Brogden RN, Faulds D. Teicoplanin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential. Drugs. 1990;40:449–86.CrossRefPubMed Campoli-Richards DM, Brogden RN, Faulds D. Teicoplanin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential. Drugs. 1990;40:449–86.CrossRefPubMed
7.
go back to reference Yasim A, Gul M, Atahan E, Ciragil P, Aral M, Ergun Y. Efficacy of vancomycin, teicoplanin and fusidic acid as prophylactic agents in prevention of vascular graft infection: an experimental study in rat. Eur J Vasc Endovasc Surg. 2006;31:274–9.CrossRefPubMed Yasim A, Gul M, Atahan E, Ciragil P, Aral M, Ergun Y. Efficacy of vancomycin, teicoplanin and fusidic acid as prophylactic agents in prevention of vascular graft infection: an experimental study in rat. Eur J Vasc Endovasc Surg. 2006;31:274–9.CrossRefPubMed
8.
go back to reference Cotran RS, Kumar V, Collins T, Robbins SL. Tissue repair: cellular growth, fibrosis and wound healing. In: Robbins pathologic basis of disease, 6th ed. Philedelphia, WB Saunders Company; 1999, pp 89–112. Cotran RS, Kumar V, Collins T, Robbins SL. Tissue repair: cellular growth, fibrosis and wound healing. In: Robbins pathologic basis of disease, 6th ed. Philedelphia, WB Saunders Company; 1999, pp 89–112.
9.
go back to reference Bandyk DF. Infection in prosthetic vascular grafts. In: Rutherford RB, editor. Vascular surgery. 5th ed. Philadelphia: Saunders; 2000. p. 733. Bandyk DF. Infection in prosthetic vascular grafts. In: Rutherford RB, editor. Vascular surgery. 5th ed. Philadelphia: Saunders; 2000. p. 733.
10.
go back to reference Giacometti A, Cirioni O, Del Prete MS, Barchiesi F, Scalise G. Shortterm exposure to membrane-active antibiotics inhibits Cryptosporidium parvum infection in cell culture. Antimicrob Agents Chemother. 2000;44:3473–5.PubMedCentralCrossRefPubMed Giacometti A, Cirioni O, Del Prete MS, Barchiesi F, Scalise G. Shortterm exposure to membrane-active antibiotics inhibits Cryptosporidium parvum infection in cell culture. Antimicrob Agents Chemother. 2000;44:3473–5.PubMedCentralCrossRefPubMed
11.
go back to reference Igari K, Kudo T, Toyofuku T, Jibiki M, Sugano N, Inoue Y. Treatment strategies for aortic and peripheral prosthetic graft infection. Surg Today. 2014;44:466–71.CrossRefPubMed Igari K, Kudo T, Toyofuku T, Jibiki M, Sugano N, Inoue Y. Treatment strategies for aortic and peripheral prosthetic graft infection. Surg Today. 2014;44:466–71.CrossRefPubMed
12.
go back to reference Palumbo R, Niscola P, Calabria S, Fierimonte S, Bevilacgua M, Scaramucci L, et al. Long- term favorable results by arteriovenous graft with Omniflow II prosthesis for hemodialysis. Nephron Clin Pract. 2009;113:76–80.CrossRef Palumbo R, Niscola P, Calabria S, Fierimonte S, Bevilacgua M, Scaramucci L, et al. Long- term favorable results by arteriovenous graft with Omniflow II prosthesis for hemodialysis. Nephron Clin Pract. 2009;113:76–80.CrossRef
13.
go back to reference Koch G, Gutschi S, Pascher O, Fruhwirth J, Hauser H. Femoropopliteal vascular replacement: vein, ePTFE or ovine collagen? Zentralbl Chir. 1996;121:761–7.PubMed Koch G, Gutschi S, Pascher O, Fruhwirth J, Hauser H. Femoropopliteal vascular replacement: vein, ePTFE or ovine collagen? Zentralbl Chir. 1996;121:761–7.PubMed
14.
go back to reference Moresetti M, Cipriani S, Dominijanni S, Pisani G, Frattarelli D, Bruno F. Basilic vein transposition versus biosynthetic prosthesis as vascular access for hemodialysis. J Vasc Surg. 2011;54:1713–9.CrossRef Moresetti M, Cipriani S, Dominijanni S, Pisani G, Frattarelli D, Bruno F. Basilic vein transposition versus biosynthetic prosthesis as vascular access for hemodialysis. J Vasc Surg. 2011;54:1713–9.CrossRef
15.
go back to reference Topel I, Betz T, Uhl C, Wiesner M, Brochner S, Steinbauer M. Use of biosynthetic prosthesis (Omniflow II®) to replace infected infrainguinal prosthetic grafts–first results. Vasa. 2012;41:215–20.CrossRefPubMed Topel I, Betz T, Uhl C, Wiesner M, Brochner S, Steinbauer M. Use of biosynthetic prosthesis (Omniflow II®) to replace infected infrainguinal prosthetic grafts–first results. Vasa. 2012;41:215–20.CrossRefPubMed
16.
go back to reference Fellmer PT, Matia I, Jonas S. Arterial allografts in vascular surgery best choice in cases of aortic graft infection? Zentralbl Chir. 2013;138:530–5.CrossRefPubMed Fellmer PT, Matia I, Jonas S. Arterial allografts in vascular surgery best choice in cases of aortic graft infection? Zentralbl Chir. 2013;138:530–5.CrossRefPubMed
17.
go back to reference Yasim A, Gul M, Cıralık H, Ergun Y. Gelatin-sealed dacron is not more susceptible to MRSA infection than PTFE graft. Eur J Endovasc Surg. 2006;32:425–30.CrossRef Yasim A, Gul M, Cıralık H, Ergun Y. Gelatin-sealed dacron is not more susceptible to MRSA infection than PTFE graft. Eur J Endovasc Surg. 2006;32:425–30.CrossRef
Metadata
Title
Which prosthesis is more resistant to vascular graft infection: polytetrafluoroethylene or Omniflow II biosynthetic grafts?
Authors
Orhan Bozoglan
Bulent Mese
Erdinc Eroglu
Serdal Elveren
Mustafa Gul
Ahmet Celik
Halil Ibrahim Yildirimdemir
Harun Ciralik
Alptekin Yasim
Publication date
01-03-2016
Publisher
Springer Japan
Published in
Surgery Today / Issue 3/2016
Print ISSN: 0941-1291
Electronic ISSN: 1436-2813
DOI
https://doi.org/10.1007/s00595-015-1141-3

Other articles of this Issue 3/2016

Surgery Today 3/2016 Go to the issue